Making a judgement on the potential curability of recurrent Renal Cell Carcinoma (RCC): Differences in global per protocol vs. investigator based assessment
By: C. Beisland, Bergen (NO)
Session: Oral presentation of the 6 best abstracts Oral presentation of the 6 best abstracts
Location: Saturday, 10 November 2018, 12:00 - 12:30, Auditorium